Metastatic Ovarian Cancer - Pipeline Review, H1 2016; New Report Launched
Metastatic Ovarian Cancer - Pipeline Review, H1 2016', provides an overview of the Metastatic Ovarian Cancer pipeline landscape. The report provides comprehensive information on the therapeutics under development for Metastatic Ovarian Cancer, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an...
View full press release